LCM
FBLG icon

Landscape Capital Management’s FibroBiologics FBLG Stock Holding History

Landscape Capital Management’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,500
Closed -$191K – 921
2025
Q3 		$191K Buy
+17,500
New +$210K 0.01% 559

Other funds holding FBLG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
ANTB
AMG National Trust Bank Greenwood Village, Colorado $4.88B AUM 24.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Landscape Capital Management's FBLG Position: Q4 2025 in Review

Landscape Capital Management sold out of FibroBiologics (FBLG) in Q4 2025, closing a stake of 17,500 shares — an estimated $191K sold.

Landscape Capital Management first reported a position in FBLG in Q3 2025 and held it in 1 quarter. The position peaked at $191K in Q3 2025. 45 funds tracked by Wall St. Rank hold FBLG as of Q4 2025.

  • Landscape Capital Management reported no remaining FibroBiologics position as of Q4 2025 after selling out during the quarter.
  • Landscape Capital Management sold 17,500 FibroBiologics shares in Q4 2025, an estimated $191K.
  • Landscape Capital Management first reported a position in FibroBiologics in Q3 2025 and held it in 1 quarter.
  • Landscape Capital Management's FibroBiologics position peaked at $191K in Q3 2025.
  • 45 funds tracked by Wall St. Rank held FibroBiologics as of Q4 2025.

Based on Landscape Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.